1,516.00
+8(+0.53%)
Currency In JPY
Address
Tennoz Ocean Square
Tokyo, 140-0002
Japan
Phone
81 3 6711 5200
Sector
Healthcare
Industry
Medical - Devices
Employees
1216
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Mr. Keisuke Suzuki | President, Chief Executive Officer & Representative Director | 0 | 1953 |
| Mr. Takeyoshi Egawa | Chief Financial Officer, Chief Risk Management Officer, Head of Corporate Management Group & Director | 0 | 1976 |
| Mr. Kenji Yamada | CCO, Chief Information Security Officer, Head of Corporate Admin Group & Director | 0 | 1971 |
| Ms. Yumiko Hoshiba | Chief Risk Management Officer, CISO, Senior Manager of Operations Depa Corporate Man Group& Director | 0 | 1962 |
| Mr. Takashi Ito | Senior Operating Officer Head of Arrhythmia Business Operations Group & Board Director | 0 | 1968 |
| Mr. Toru Takamiya | Executive Officer, Head of R&D and Production Group & Director | 0 | 1964 |
| Mr. Atsuhiro Suzuki | Vice President, Chief Operating Officer & Representative Director | 0 | 1958 |
| Mr. Tadashi Idei | Senior Operating Officer, Head of Regulatory Affairs Group & Director | 0 | 1965 |
| Mr. Tatsuya Murase | Chief Commercial Officer, Head of Business Operations Headquarters & Director | 0 | 1973 |
| Naohiro Nakada | Senior Operating Officer & GM of EP Division Arrhythmia Business Operations Group | 0 | N/A |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.